Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. [electronic resource]
- Biochemical and biophysical research communications Apr 1999
- 361-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0006-291X
10.1006/bbrc.1999.0472 doi
6-Aminonicotinamide--pharmacology Blotting, Western Carmustine--pharmacology Carrier Proteins--genetics Cell Survival--drug effects Cisplatin--pharmacology Colonic Neoplasms--genetics Cross-Linking Reagents--pharmacology DNA Damage--drug effects Dose-Response Relationship, Drug Drug Resistance, Neoplasm Endoplasmic Reticulum Chaperone BiP Heat-Shock Proteins Humans Melphalan--pharmacology Molecular Chaperones--genetics NAD--analogs & derivatives Poly Adenosine Diphosphate Ribose--metabolism Time Factors Tumor Cells, Cultured Up-Regulation--drug effects